Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Photobiomodulation With REd vs BluE Light (REBEL) [NA]

View source ↗

Summary

A recruiting Aston University trial compares red versus blue light photobiomodulation for dry eye conditions, including meibomian gland dysfunction and blephari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aston University | Conditions: Dry Eye Syndromes, Meibomian Gland Dysfunction | NA | Status: RECRUITING